CLDX Shares Outstanding History



Below is a table of the CLDX shares outstanding history going back to 2/25/2010:

Date CLDX Shares Outstanding
2/25/20102.11M
3/22/20102.12M
5/3/20102.12M
8/2/20102.13M
11/1/20102.14M
12/17/20102.14M
2/28/20112.14M
4/28/20112.17M
8/1/20112.94M
10/31/20112.94M
2/29/20123.81M
4/26/20123.92M
7/31/20123.95M
10/30/20124.13M
2/28/20135.37M
4/24/20135.39M
7/29/20135.40M
10/29/20135.41M
2/19/20145.95M
4/22/20145.96M
7/28/20145.96M
10/31/20145.97M
2/17/20155.97M
4/22/20156.57M
7/28/20156.57M
10/27/20156.58M
2/16/20166.58M
4/26/20166.58M
7/31/20166.70M
10/31/20166.75M
3/6/20178.21M
4/30/20178.34M
7/31/20178.56M
10/31/20179.07M
2/28/20189.40M
5/3/20189.56M
7/31/201810.83M
10/31/201811.50M
2/11/201911.50M
2/28/201912.44M
4/30/201913.77M
7/31/201915.02M
10/31/201916.13M
3/13/202017.57M
4/30/202018.94M
7/31/202039.13M
10/31/202039.57M
3/22/202139.61M
4/30/202139.61M
7/31/202146.48M
10/31/202146.66M
2/17/202246.74M
4/29/202246.75M
7/29/202246.77M
10/31/202247.10M
4/28/202347.25M
7/31/202347.26M
10/27/202347.26M
2/14/202455.90M

Also see: CLDX Market Cap History
CLDX YTD Return
CLDX Historical Shares Outstanding:
+26.40% CAGR
CLDX Historical Shares Outstanding: +26.40% CAGR

Mouse over chart for data details
2/25/2010 ...2/14/2024
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors. We show 59 historical shares outstanding datapoints in our coverage of CLDX's shares outstanding history.

Understanding the changing numbers of CLDX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CLDX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CLDX by allowing them to research CLDX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree CLDX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Celldex Therapeutics (CLDX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

CLNN Shares Outstanding History
CLOV Shares Outstanding History
CLPT Shares Outstanding History
CLRB Shares Outstanding History
CLSD Shares Outstanding History
CLSN Shares Outstanding History
CLVS Shares Outstanding History
CLXT Shares Outstanding History
CMAX Shares Outstanding History
CMD Shares Outstanding History
More Healthcare companies »

 

CLDX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.